Media Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources. Media… Homepage Media Our Latest Press Releases Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article Changes to the Composition of Guerbet’s Board of Directors Read the article Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article - Any - 2026 2025 2024 2023 2022 2021 2020 2019 2018 ApplyClear Filters Guerbet announces the appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Read the article CHMP grants positive opinion for Elucirem™ (gadopiclenol) pediatric indication extension under two years of age Read the article Financial agenda for 2026 Read the article Guerbet: Innovation and French Cooperation in the Spotlight at RSNA 2025 Read the article Revenue at September 30, 2025 Read the article H1 2025 results Read the article Change in General Management Read the article Adjustment of 2025 full-year financial targets Read the article Changes in the composition of the Guerbet Board of Directors Read the article ‹ 1 Current page2 3 4 5 6 7 8 9 ›
Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT Read the article
Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil) Read the article
Guerbet announces the appointment of Mr. François Convenant as Senior Vice President of Interventional Radiology and his entry into the Executive Committee Read the article
CHMP grants positive opinion for Elucirem™ (gadopiclenol) pediatric indication extension under two years of age Read the article
